胆固醇酯转移蛋白影响脓毒症高密度脂蛋白水平与生存
研究对200例急诊脓毒症患者(早期感染队列)行HDL相关基因靶向重测序,发现CETP罕见错义变异rs1800777-A与脓毒症期间HDL-C显著降低相关。携带A等位基因者(n=10)生存下降、器官衰竭更多、器官支持需求更大。该发现在VASST队列(n=632)和SPHICU2队列(n=203)中重复验证,携带者(分别为n=35和n=12)28天生存率显著降低。孟德尔随机化结果与遗传性HDL降低是脓毒症生存下降的因果因素相一致。
要点
- 在早期感染队列200例急诊脓毒症患者中,CETP罕见错义变异rs1800777-A与脓毒症期间HDL-C水平显著降低相关。
- 携带rs1800777-A者(n=10)较非携带者生存下降、器官衰竭更多、器官支持需求更大。
- VASST队列(n=632)中rs1800777-A携带者(n=35)28天生存率显著降低,SPHICU2队列(n=203)中携带者(n=12)同样28天生存率显著降低。
- 孟德尔随机化结果与遗传性HDL水平降低是脓毒症生存下降的因果因素相一致。
- 作者认为CETP是脓毒症期间HDL水平和临床结局的关键调节因子,HDL在脓毒症中可能起关键作用。
适用人群与场景
- 急诊科收治的脓毒症患者(早期感染队列,n=200);候选变异进一步在VASST试验队列(n=632)和圣保罗医院重症监护室2(SPHICU2)队列(n=203)中评估。
研究设计与关键结果
- 研究类型:遗传关联研究,对HDL相关基因行靶向重测序,并在VASST和SPHICU2队列中重复验证,辅以孟德尔随机化分析。
- 早期感染队列纳入200例急诊脓毒症患者,发现CETP罕见错义变异rs1800777-A与脓毒症期间HDL-C水平显著降低相关。
- 携带A等位基因者(n=10)较非携带者生存下降、器官衰竭更多、需要器官支持更多。
- VASST队列(n=632)中rs1800777-A携带者(n=35)28天生存率显著降低;SPHICU2队列(n=203)中携带者(n=12)28天生存率显著降低。
- 孟德尔随机化结果与遗传性HDL水平降低是脓毒症生存下降的因果因素相一致。
证据类型、等级与局限
- 证据类型:遗传关联研究(靶向重测序+重复验证队列+孟德尔随机化)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为CETP是脓毒症期间HDL水平和临床结局的关键调节因子,HDL在脓毒症中可能起关键作用。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
RATIONALE: High-density lipoprotein (HDL) cholesterol (HDL-C) levels decline during sepsis, and lower levels are associated with worse survival. However, the genetic mechanisms underlying changes in HDL-C during sepsis, and whether the relationship with survival is causative, are largely unknown.
OBJECTIVES: We hypothesized that variation in genes involved in HDL metabolism would contribute to changes in HDL-C levels and clinical outcomes during sepsis.
METHODS: We performed targeted resequencing of HDL-related genes in 200 patients admitted to an emergency department with sepsis (Early Infection cohort). We examined the association of genetic variants with HDL-C levels, 28-day survival, 90-day survival, organ dysfunction, and need for vasopressor or ventilatory support. Candidate variants were further assessed in the VASST (Vasopressin versus Norepinephrine Infusion in Patients with Septic Shock Trial) cohort (n = 632) and St. Paul's Hospital Intensive Care Unit 2 (SPHICU2) cohort (n = 203).
MEASUREMENTS AND MAIN RESULTS: We identified a rare missense variant in CETP (cholesteryl ester transfer protein gene; rs1800777-A) that was associated with significant reductions in HDL-C levels during sepsis. Carriers of the A allele (n = 10) had decreased survival, more organ failure, and greater need for organ support compared with noncarriers. We replicated this finding in the VASST and SPHICU2 cohorts, in which carriers of rs1800777-A (n = 35 and n = 12, respectively) had significantly reduced 28-day survival. Mendelian randomization was consistent with genetically reduced HDL levels being a causal factor for decreased sepsis survival.
CONCLUSIONS: Our results identify CETP as a critical regulator of HDL levels and clinical outcomes during sepsis. These data point toward a critical role for HDL in sepsis.
参考来源
- Trinder M, Genga KR, Kong HJ, et al. Cholesteryl Ester Transfer Protein Influences High-Density Lipoprotein Levels and Survival in Sepsis. Am J Respir Crit Care Med. 2019. PMID: 30321485. doi:10.1164/rccm.201806-1157OC
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。